Clinical Nurse Specialist in Woodbridge, VA Accepting Medicare

3 Clinical Nurse Specialist nurses found. Showing 1 - 3

Abu Sheriff, NP Clinical Nurse Specialist - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 12731 Marblestone Dr Ste 200, Woodbridge, VA 22192 Phone: 703-897-4700    Fax: 703-897-6603

Ronney O Alvarado, Clinical Nurse Specialist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12789 Cara Drive, Woodbridge, VA 22192 Phone: 703-490-5251

Ms. M. Bernadette Macdonald, APRN-PMH Clinical Nurse Specialist - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 12584 Darby Brook Ct, Woodbridge, VA 22192 Phone: 703-408-0727    Fax: 703-491-2388

News Archive

HIV combination antiretroviral drug therapy key to saving the lives of African children

Letting nurses and other trained health care workers deliver that therapy and monitor patients, especially when doctors are in short supply, is just as important to saving lives, according to a new study by the University of Alabama at Birmingham (UAB).

Mild maternal infections can have permanent impacts on offspring immunity

During pregnancy, mild infections in the mother can have permanent and tissue-specific impacts on offspring immunity, according to a new study in mice.

FDA approves Amneal Pharmaceuticals' Tramadol/APAP tablets

Amneal Pharmaceuticals is pleased to announce that it received U.S. FDA approval to manufacture combination Tramadol HCl in 37.5 mg strength and Acetaminophen in 325 mg strength (Tramadol/APAP) in tablet form effective December 9, 2009. Amneal's generic is an AB-rated, therapeutically equivalent alternative to Ultracet® (a licensed trademark of Ortho-McNeil Janssen). U.S. sales of Tramadol/APAP were $61 MM according to June 2009 IMS Health market data.

Study shows amyloid formation may link type 2 diabetes and Alzheimer disease

The pathological process amyloidosis, in which misfolded proteins (amyloids) form insoluble fibril deposits, occurs in many diseases, including Alzheimer disease (AD) and type 2 diabetes mellitus (T2D).

BioNumerik Pharmaceuticals commences patient treatment in Tavocept Phase III trial

BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.

Read more Medical News

› Verified 3 days ago